These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21083483)
1. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis. Wong P; Pham R; Bruenner BA; James CA Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483 [No Abstract] [Full Text] [Related]
2. Dried blood spot sampling for quantitative bioanalysis: time for a revolution? Spooner N Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481 [No Abstract] [Full Text] [Related]
3. A glowing future for dried blood spot sampling. Spooner N Bioanalysis; 2010 Aug; 2(8):1343-4. PubMed ID: 21083330 [No Abstract] [Full Text] [Related]
4. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays. Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341 [TBL] [Abstract][Full Text] [Related]
5. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples. Barfield M; Ahmad S; Busz M Bioanalysis; 2011 May; 3(9):1025-30. PubMed ID: 21545350 [TBL] [Abstract][Full Text] [Related]
6. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry. Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496 [TBL] [Abstract][Full Text] [Related]
7. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS. Lad R Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493 [TBL] [Abstract][Full Text] [Related]
8. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. Denniff P; Spooner N Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489 [TBL] [Abstract][Full Text] [Related]
9. The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry. Keevil BG Clin Biochem; 2011 Jan; 44(1):110-8. PubMed ID: 20599869 [TBL] [Abstract][Full Text] [Related]
10. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351 [TBL] [Abstract][Full Text] [Related]
11. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system. Heinig K; Wirz T; Gajate-Perez A Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495 [TBL] [Abstract][Full Text] [Related]
12. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS. Michi M; Ferrari L Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494 [TBL] [Abstract][Full Text] [Related]
13. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Denniff P; Spooner N Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339 [TBL] [Abstract][Full Text] [Related]
14. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling. Clark GT; Giddens G; Burrows L; Strand C Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022 [TBL] [Abstract][Full Text] [Related]
15. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds. Bowen CL; Hemberger MD; Kehler JR; Evans CA Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490 [TBL] [Abstract][Full Text] [Related]
16. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS. Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic considerations as to when to use dried blood spot sampling. Emmons G; Rowland M Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484 [TBL] [Abstract][Full Text] [Related]
18. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods. Abu-Rabie P; Spooner N Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338 [TBL] [Abstract][Full Text] [Related]
19. Assessment of DBS technology for the detection of therapeutic antibodies. Prince PJ; Matsuda KC; Retter M; Scott G Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345 [TBL] [Abstract][Full Text] [Related]
20. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. D'Arienzo CJ; Ji QC; Discenza L; Cornelius G; Hynes J; Cornelius L; Santella JB; Olah T Bioanalysis; 2010 Aug; 2(8):1415-22. PubMed ID: 21083342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]